Who owns Galera Therapeutics Inc?
- Ticker: GRTX
- CUSIP Number: 36338d108
Tip: Access positions for across all investors
Analyze quarterly positions in Galera Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Galera Therapeutics stock
Who bought or sold Galera Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| GSA Capital Partners | 3.6M | $509k | -7% | Mar 2024 |
|
| Blackstone Group | 1.7M | $235k | 0% | Mar 2024 |
|
| Standard Life Aberdeen | 898k | $126k | 0% | Mar 2024 |
|
| Vanguard Group | 448k | $63k | 0% | Mar 2024 |
|
| Geode Capital Management | 440k | $62k | 41% | Mar 2024 |
|
| BlackRock | 357k | $50k | -4% | Mar 2024 |
|
| UBS Group | 294k | $41k | 2303% | Mar 2024 |
|
| Susquehanna International | 286k | $40k | 190% | Mar 2024 |
|
| Summit Trail Advisors | 148k | $21k | 100% | Mar 2024 |
|
| Millennium Management | 77k | $11k | 100% | Mar 2024 |
|
| Manchester Financial | 72k | $10k | 227% | Mar 2024 |
|
| Northern Trust | 69k | $9.7k | 0% | Mar 2024 |
|
| Virtu Financial | 57k | $8.0k | 359% | Dec 2023 |
|
| Kestra Advisory Services | 36k | $5.2k | -58% | Dec 2023 |
|
| Royal Bank of Canada | 35k | $0 | -1% | Mar 2024 |
|
| Group One Trading | 33k | $4.6k | -50% | Mar 2024 |
|
| Good Life Advisors | 31k | $4.4k | 0% | Mar 2024 |
|
| Level Four Advisory Services | 26k | $3.8k | 0% | Mar 2024 |
|
| XTX Topco | 25k | $3.5k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 22k | $3.1k | 0% | Mar 2024 |
|
| Vontobel Holding | 20k | $2.8k | 0% | Mar 2024 |
|
| LPL Financial | 18k | $2.5k | -50% | Mar 2024 |
|
| Hrt Financial | 16k | $2.0k | 6% | Mar 2024 |
|
| Two Sigma Securities | 12k | $1.7k | 100% | Mar 2024 |
|
| J.w. Cole Advisors | 12k | $1.7k | 0% | Mar 2024 |
|
| Citadel Advisors | 10k | $1.4k | -98% | Mar 2024 |
|
| Parallel Advisors | 7.9k | $1.1k | 0% | Mar 2024 |
|
| Natixis | 5.0k | $774.000000 | 0% | Mar 2024 |
|
| Us Bancorp | 3.0k | $420.000000 | 0% | Mar 2024 |
|
| Morgan Stanley | 2.8k | $396.056900 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 1.4k | $195.713700 | 6% | Mar 2024 |
|
| LifeSteps Financial | 870.00 | $121.974000 | 100% | Mar 2024 |
|
| FMR | 757.00 | $105.980000 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 24.00 | $3.000000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 2.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Galera Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sofinnova Ventures | Sep 2023 | 3.1M | $540k |
| Bridgeway Capital Management | Sep 2023 | 112k | $20k |
| Resources Investment Advisors | Sep 2023 | 21k | $3.6k |
| Jane Street | Dec 2023 | 11k | $1.7k |
| WealthCollab | Dec 2023 | 3.9k | $570.069000 |
| Bank of America Corporation | Dec 2023 | 500.00 | $72.000000 |
| Simplex Trading | Dec 2023 | 391.00 | $0 |